ASP Isotopes (NASDAQ:ASPI – Get Free Report) and International Flavors & Fragrances (NYSE:IFF – Get Free Report) are both materials companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability.
Volatility & Risk
ASP Isotopes has a beta of 3.59, indicating that its share price is 259% more volatile than the S&P 500. Comparatively, International Flavors & Fragrances has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500.
Analyst Recommendations
This is a summary of current recommendations for ASP Isotopes and International Flavors & Fragrances, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ASP Isotopes | 1 | 0 | 2 | 0 | 2.33 |
| International Flavors & Fragrances | 1 | 6 | 12 | 0 | 2.58 |
Earnings & Valuation
This table compares ASP Isotopes and International Flavors & Fragrances”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| ASP Isotopes | $30.85 million | 15.85 | -$175.09 million | ($1.32) | -2.42 |
| International Flavors & Fragrances | $10.78 billion | 1.97 | -$361.00 million | $1.09 | 76.49 |
ASP Isotopes has higher earnings, but lower revenue than International Flavors & Fragrances. ASP Isotopes is trading at a lower price-to-earnings ratio than International Flavors & Fragrances, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
16.8% of ASP Isotopes shares are held by institutional investors. Comparatively, 96.0% of International Flavors & Fragrances shares are held by institutional investors. 14.4% of ASP Isotopes shares are held by company insiders. Comparatively, 1.1% of International Flavors & Fragrances shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares ASP Isotopes and International Flavors & Fragrances’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ASP Isotopes | -427.98% | -64.99% | -32.20% |
| International Flavors & Fragrances | 2.78% | 7.11% | 3.96% |
Summary
International Flavors & Fragrances beats ASP Isotopes on 9 of the 14 factors compared between the two stocks.
About ASP Isotopes
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
About International Flavors & Fragrances
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B’s Food & Beverage division and the food protection business of N&B’s Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.
